Skip to content
Topic
medicine
15 markets across Kalshi and Polymarket, $4.3K traded today.
fda
drug approval
pharmaceuticals
science
regulation
health
vaccines
biotechnology
psychedelics
retatrutide
skin cancer
tech
Market
Chance
24h
Last 24h
Best price
Volume 24h
FDA approves Retatrutide this year?
Tech & Science
·
Ends Dec 30, 2026
3%
−2¢
3.9¢
$2.4K
FDA approves skin cancer vaccine by...?
December 31, 2027
·
Tech & Science
·
Ends Jun 30, 2027
65%
—
65¢
$758
Will the FDA approve any psychedelic substance for medical use this year?
Tech & Science
·
Ends Dec 31, 2026
25%
—
28¢
$633
When will the FDA reclassify BPC-157 to Category 1?
Before November
·
Tech & Science
·
Ends Aug 31, 2026
12%
—
20¢
$492
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Before Jan 1, 2027
·
Tech & Science
·
Ends Dec 31, 2026
36%
—
39¢
$12
Will the FDA approve a cure for Type 1 diabetes before 2033?
Tech & Science
·
Ends Dec 31, 2032
39%
—
39¢
$1
Will the FDA approve retatrutide?
Before Jan 1, 2027
·
Tech & Science
·
Ends Dec 31, 2026
6%
—
6¢
$0
Will the FDA approve MDMA for PTSD?
Before Jan 1, 2032
·
Tech & Science
·
Ends Dec 31, 2026
55%
—
58¢
—
Will the FDA approve VERVE-102?
Before 2035
·
Tech & Science
·
Ends Dec 31, 2029
84%
—
87¢
—
Will the FDA approve intismeran autogene (V940/mRNA-4157)?
Before Jan 1, 2028
·
Tech & Science
·
Ends Mar 31, 2027
93%
—
95¢
—
Will the FDA approve CagriSema?
Before Jan 1, 2028
·
Tech & Science
·
Ends Sep 30, 2026
81%
—
84¢
—
Skin cancer vaccine BLA submitted by...?
June 30, 2027?
·
Tech & Science
·
Ends Mar 31, 2027
88%
—
88¢
—
FDA decision: Venglustat by Sanofi (in 2026)
Economics
·
Ends Dec 31, 2026
82%
—
85¢
—
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Economics
·
Ends Dec 31, 2026
89%
—
92¢
—
Hantavirus vaccine in 2026?
Weather
·
Ends Dec 31, 2026
4%
—
4¢
—
Routeur
Feed
Explore
Insights
Board
Search
⌘K
Feed
Explore
Insights
Board
Sign in